文献速递主动脉疾病

骨质疏松对降主动脉瘤腔内修复术后生存的预后影响

Prognostic Impact of Osteoporosis on Survival Following Endovascular Repair for Descending Thoracic Aortic Aneurysms.
PubMed 文献 · Ann Vasc Surg · 2026-08-19

本研究回顾性纳入215例2007至2019年因降主动脉瘤行首次TEVAR的患者,通过术前CT第11胸椎HU值评估骨密度,骨质疏松定义为BMD<110 HU。114例(53.0%)存在骨质疏松,其中位随访68个月,骨质疏松组总体生存率及免于动脉瘤相关死亡率均更低,多因素Cox回归显示骨质疏松与全因死亡独立相关(HR 2.05,95%CI 1.16-3.63,P=0.014)。

要点

  • TEVAR术前CT测得的骨质疏松(BMD<110 HU)与远期全因死亡风险独立相关。
  • 骨质疏松患者TEVAR术后5、7、10年总体生存率均显著低于非骨质疏松患者。
  • CT骨密度评估可作为TEVAR术前预估预期寿命的实用影像学标志物。

核心结论

  • 骨质疏松与降主动脉瘤TEVAR术后远期生存率降低独立相关。
  • CT评估的骨密度可能作为预估该人群预期寿命的实用影像学标志物。

研究设计与样本

  • 回顾性单中心队列研究,纳入2007至2019年因降主动脉瘤行首次TEVAR的215例患者。
  • 术前CT第11胸椎HU值评估骨密度,骨质疏松定义为BMD<110 HU,按骨质疏松状态分层比较远期结局。
  • 采用单因素和多因素Cox模型分析全因死亡的风险比。

主要发现

  • 114例(53.0%)存在骨质疏松,骨质疏松组年龄更高(77.1±6.7 vs. 71.2±9.9岁)且骨密度更低(72.2±24.2 vs. 141.8±27.9 HU,P<0.0001)。
  • 中位随访68个月,骨质疏松组总体生存率更低(5、7、10年生存率69.0%、64.0%、48.3% vs. 86.0%、82.9%、76.9%;log-rank P=0.0003)。
  • 骨质疏松组免于动脉瘤相关死亡率也更低(5、7、10年生存率91.6%、91.6%、82.6% vs. 97.9%、97.9%、94.7%;log-rank P=0.048)。
  • 多因素Cox回归中骨质疏松与全因死亡独立相关(HR 2.05,95%CI 1.16-3.63,P=0.014)。

临床怎么用

  • TEVAR术前可利用常规CT测量第11胸椎HU值评估骨密度,识别骨质疏松患者。
  • 对合并骨质疏松的降主动脉瘤患者,应充分告知远期生存预期可能较低,并加强术后随访管理。

局限性

  • 回顾性单中心设计,样本量有限,结果外推需谨慎。
  • 骨质疏松仅基于CT HU值定义,未与双能X线吸收法确诊对照。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The prognostic impact of osteoporosis after thoracic endovascular aortic repair (TEVAR) for descending thoracic aortic aneurysm (DTAA) remains unclear. METHODS: This retrospective single-center cohort included 215 patients who underwent primary TEVAR for DTAA between 2007 and 2019. Bone mineral density (BMD) was estimated using Hounsfield units (HU) at the 11th thoracic vertebra on preoperative computed tomography, and osteoporosis was defined as BMD <110 HU. Patients were stratified by osteoporosis status, and long-term outcomes were compared. Hazard ratios for all-cause mortality were analyzed using univariate and multivariate models. RESULTS: Overall, 114 patients (53.0%) had osteoporosis. Patients with osteoporosis were older and had lower BMD than those without osteoporosis (age, 77.1 ± 6.7 vs. 71.2 ± 9.9 years; BMD, 72.2 ± 24.2 vs. 141.8 ± 27.9 HU; P < 0.0001). During a median follow-up of 68 months, overall survival was lower in patients with osteoporosis than in those without osteoporosis (5-, 7-, and 10-year survival, 69.0%, 64.0%, and 48.3% vs. 86.0%, 82.9%, and 76.9%; log-rank P = 0.0003). Freedom from aneurysm-related mortality was also lower in patients with osteoporosis (5-, 7-, and 10-year survival, 91.6%, 91.6%, and 82.6% vs. 97.9%, 97.9%, and 94.7%; log-rank P = 0.048). In multivariable Cox regression, osteoporosis was independently associated with all-cause mortality (hazard ratio, 2.05; 95% confidence interval, 1.16-3.63; P = 0.014). CONCLUSION: Osteoporosis was independently associated with reduced long-term survival after TEVAR for DTAA. CT-assessed BMD may provide a practical imaging-based marker for estimating life expectancy in this population.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Kasa K, Ohki T, Shukuzawa K, et al. Prognostic Impact of Osteoporosis on Survival Following Endovascular Repair for Descending Thoracic Aortic Aneurysms. Ann Vasc Surg. 2026. PMID: 42617686. doi:10.1016/j.avsg.2026.08.008

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。